10x Genomics is trading 6.1% higher at $74.36, with no clear company-specific catalyst identified for September 15, 2026.
- Recent coverage highlights an earlier CFO stock sale.
- The latest investor-relations listing shows no September 15 announcement.
- Broader markets are modestly lower ahead of the Federal Reserve meeting, which does not clearly explain the isolated gain.